Washington
Ended · Pillsbury Q3 2026Lobbying Q3 None no reports
YoY n/a vs Q3 2025
Members 0 all time
Buys / sells 0 / 0 0 trades
EXPO
EXPONENT INC$77.66 +0.23 (+0.30%)
Oct 26 4:00 PM ET · prev $77.43
Market cap
$3.7B
Mid cap
Consensus
Buy
80% Buy or better · 10 analysts
Median target
$90.00
+16% · range $72.00–90.00
Next earnings
Oct 29
in 2 days
1 year
+14.6%
from $67.77 · Oct 27
30 days
+20.7%
from $64.35
52-week range
$53.67–79.79
−3% from high · low May 14
Avg volume 20D
604.3K
shares / day
Short interest
🔒 Subscribers only
Insider net
−$1.7M
1 buyer · 5 sellers · since Mar 11
New fund stakes
3
Q2 2026 13F · 2 exits
Filing reports
7
analyzed by SecBot
SecBot read MIXED 1 report · latest
Balance 0 bearish · 0 bullish · 1 neutral oldest → newest, height = score
Avg score ·High conf. 1/1 ·Next Earnings date, Oct 29, 2026
Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
No data for this timeframe.
- S Apr 15 1 insider sell $264.6K at $67.70
- R Apr 30 Exponent reported Q1 2026 results with total revenues up 14% to $166…
- S May 13 to May 26 4 days of insider sells: $717.8K by 5 insiders, avg $55.74
- S Jun 15 1 insider sell $235.3K at $57.13
- I Jun 30 3 funds open new positions (13F)
- S Jul 15 1 insider sell $109.0K at $62.78
- S Aug 17 1 insider sell $113.1K at $66.28
- B Sep 18 1 insider buy $12.6K at $68.45
Signal stack
Where each data set points today.
- InsidersBEARISH
1 insider bought $12.6K at an average $68.45. 5 insiders sold $1.7M. Price is 13% above their cost.
- InstitutionsMIXED
Q2 2026: 31 added (3 new), 32 trimmed or exited. Largest new: Point72 Asset Management, $23.2M, Balyasny Asset Management $12.1M.
- AnalystsBULLISH
8 of 10 rate it Buy or better. Median target $90.00 (+16%).
- TrendUPTREND
12% above its 50-day average.
Who's buying
13F· Q2 20263
new positions
2
exits
$46.5M
in new stakes
| Fund | Move | Value |
|---|---|---|
| JPMORGAN CHASE & CO | ADD | $28.9M |
| GOLDMAN SACHS GROUP INC | TRIM | $26.2M |
| Point72 Asset Management, L.P. | NEW | $23.2M |
| BAMCO INC /NY/ | TRIM | $21.4M |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | DOUBLED | $16.0M |
| Qube Research & Technologies Ltd | DOUBLED | $13.8M |
| Trexquant Investment LP | ADD | $12.5M |
| BALYASNY ASSET MANAGEMENT L.P. | NEW | $12.1M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
10 analysts 80% rate it Buy or better
12-month targets · 3 analysts
$77.66 $72.00 $90.00 $90.00
Price is inside the target range. Median implies +16%.Targets as of Oct 27, 2026.
Recent actions
| Date | Firm | Rating |
|---|---|---|
| Jul 31, 2026 | UBS MAINTAIN | Neutral |
| Jul 31, 2026 | JP Morgan MAINTAIN | Overweight |
| May 15, 2026 | JP Morgan MAINTAIN | Overweight |
| May 1, 2026 | UBS MAINTAIN | Neutral |
Insider ledger
Form 4$12.6K
bought · 1 insider
$1.7M
sold · 5 insiders
+13.5%
vs their $68.45 cost
| Date | Insider | Type | Value |
|---|---|---|---|
| Sep 18, 2026 | Souri Shukri Jeries Group Vice President | BUY | $12.6K |
| Aug 17, 2026 | Corrigan Catherine Chief Executive Officer | EXERCISE | $69.1K |
| Aug 17, 2026 | Corrigan Catherine Chief Executive Officer | SELL | $113.1K |
| Jul 28, 2026 | Corrigan Catherine Chief Executive Officer | EXERCISE | $474.3K |
| Jul 15, 2026 | Corrigan Catherine Chief Executive Officer | EXERCISE | $69.1K |
| Jul 15, 2026 | Corrigan Catherine Chief Executive Officer | SELL | $109.0K |
| Jun 25, 2026 | Corrigan Catherine Chief Executive Officer | EXERCISE | $200.0K |
| Jun 15, 2026 | Corrigan Catherine President & CEO | EXERCISE | $81.9K |
Earnings setup
EstimatesOct 29
reports in 2 days
Revision history: 🔒 Fresh data, subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data, subscribers only | |||
| Next Q | 🔒 Fresh data, subscribers only | |||
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Short side
FINRA· Oct 15, 2026🔒 Subscribers only
shares short
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 29, 2026 Other
Exponent Hosts Investor Day
Event showcased the multidisciplinary science and engineering behind its growth Event showcased the
Sep 18, 2026 Insider
Souri Shukri Jeries bought 184 shares
Group Vice President @ $68.45 ($12.6K)
Aug 17, 2026 Insider
Corrigan Catherine acquired via exercise 2,379 shares
Chief Executive Officer @ $29.05 ($69.1K)
Aug 17, 2026 Insider
Jul 9, 2026 SEC Corrigan Catherine sold 1,707 shares
Chief Executive Officer @ $66.28 ($113.1K)
Exponent, Inc. announced it will report its fiscal Q2 2026 results on July 30, 2026.
PRESS-RELEASE — Impact 1/10
Jun 30, 2026 Inst.
JPMORGAN CHASE & CO — ADD
481,260 shares ($28.9M)
Jun 30, 2026 Inst.
May 27, 2026 SEC GOLDMAN SACHS GROUP INC — TRIM
446,274 shares ($26.2M)
Two group vice presidents at Exponent (EXPO) sold a combined $213K in open-market transactions over the past week…
CLUSTER — Impact 2/10
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Recent
Sep 29, 2026
Press release
Exponent Hosts Investor Day
Event showcased the multidisciplinary science and engineering behind its growth Event showcased the multidisciplinary science and engineering behind…
Jul 30, 2026
Earnings date
EXPO Q2 2026 Earnings Scheduled — 2026-07-30
Jul 9, 2026
Earnings
Exponent to Announce Second Quarter of Fiscal Year 2026 Results and Host Quarterly Conference Call on July 30, 2026
MENLO PARK, Calif., July 09, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO), today announced that it will report Second Quarter of fiscal…
Jun 17, 2026
Press release
Exponent to Host Investor Day at Phoenix Test & Engineering Center
Company to showcase differentiated scientific and engineering capabilities, multidisciplinary expertise, and innovation-driven growth strategy…
Jun 15, 2026
Short interest
Short Interest: EXPO up 33% to 2.7M shares
Settlement 2026-06-15 | Days to cover: 4.50 | ≈5.60% of shares outstanding (est.)
SecBot reports
7 filings · 1 bullish · 0 bearish · 1 mixed · 5 neutral- NEUTRAL PRESS-RELEASEJul 9, 2026
Exponent, Inc. announced it will report its fiscal Q2 2026 results on July 30, 2026.
- NEUTRAL CLUSTERMay 27, 2026
Two group vice presidents at Exponent (EXPO) sold a combined $213K in open-market transactions…
Sales are too small and non-senior to carry trading signal. No follow-up actions warranted unless future filings show a dramatic escalation in selling dollar amounts or C-suite participation…
- NEUTRAL CLUSTERMay 19, 2026
Four EXPO insiders, including the President & CEO, sold shares totaling $504K in open-market sales…
This cluster is economically immaterial at 0.018% of market cap. The CEO's sale alongside an option exercise is a routine liquidity event. No bearish read-through warranted. Monitor next quarterly…
- NEUTRAL CLUSTERMay 15, 2026
Three EXPO insiders, including the CEO and two Group VPs, sold a total of $406K in open-market…
This cluster is routine and non-informative. The CEO's sales are tied to option exercise/tax withholding, and the VP sales are small relative to market cap. No bearish read-through warranted…
All EXPO filing & press-release reports (7)
- PRESS-RELEASE reportJul 9, 2026
- CLUSTER reportMay 27, 2026
- CLUSTER reportMay 19, 2026
- CLUSTER reportMay 15, 2026
- CLUSTER reportMay 13, 2026
- PRESS-RELEASE reportApr 30, 2026
- 8-K reportApr 30, 2026